Gross P M, Weaver D F, Bowers R J, Nag S, Ho L T, Pang J J, Espinosa F J
Department of Surgery (Neurosurgery), Queen's University, Kingston, Ontario, Canada.
Neuropharmacology. 1994 Jul;33(7):915-27. doi: 10.1016/0028-3908(94)90190-2.
A solution containing S-nitroso-N-acetylpenicillamine (SNAP), a nitric oxide (NO.-releasing compound, was microinjected in doses of 0.25-2 mumol into a lateral ventricle of conscious rats. SNAP produced dose-dependent convulsions similar to those associated with limbic stimulation, such as tonic extension of the hindlimbs and tail, and dystonia of the forepaws. At 2 mumol, SNAP evoked hyperventilation (arterial hypocapnia), arterial hyperglycemia and caused necrotic lesions of periventricular gray (e.g. lateral septal nucleus) and white matter structures. In the caudate nucleus and lateral septal nucleus ipsilateral to injection, SNAP elicited a bipolar metabolic pattern of low glucose metabolism proximal to the ventricle with higher values occurring more distally. In control studies, we proved that the residue of SNAP decomposition, N-acetylpenicillamine disulfide injected intraventricularly (2 mumol), was without physiological, behavioral, or histological effects. Ventricular pretreatment with methylene blue (2 nmol), a putative inhibitor of guanylate cyclase and superoxide generator, suppressed several of the behavioral manifestations of 1 mumol SNAP, such as the forepaw dystonia, squinting, and facial clonus, but was ineffective on the physiological and histological variables affected by the 2 mumol SNAP dose. Another NO. donor, sodium nitroprusside (2 mumol), produced fewer behavioral and cytotoxic effects over a 55-min observation period, but caused more intense and widely distributed metabolic stimulation, especially in commissural and projection white matter tracts. The results are the basis for a conscious rat model using intraventricular injection of nitrocompounds to examine the physiological, behavioral, metabolic and cytotoxic properties of NO. in the brain.
将含有一氧化氮(NO)释放化合物S-亚硝基-N-乙酰青霉胺(SNAP)的溶液以0.25 - 2 μmol的剂量微量注射到清醒大鼠的侧脑室。SNAP产生剂量依赖性惊厥,类似于与边缘系统刺激相关的惊厥,如后肢和尾巴的强直性伸展以及前爪的肌张力障碍。在2 μmol时,SNAP诱发过度通气(动脉低碳酸血症)、动脉高血糖,并导致脑室周围灰质(如外侧隔核)和白质结构的坏死性病变。在注射同侧的尾状核和外侧隔核中,SNAP引发了一种双相代谢模式,脑室近端葡萄糖代谢较低,而更远端的值更高。在对照研究中,我们证明向脑室内注射SNAP分解产物N-乙酰青霉胺二硫化物(2 μmol)没有生理、行为或组织学效应。用亚甲蓝(2 nmol)进行脑室预处理,亚甲蓝是一种假定的鸟苷酸环化酶抑制剂和超氧化物生成剂,可抑制1 μmol SNAP的几种行为表现,如前爪肌张力障碍、斜视和面部阵挛,但对受2 μmol SNAP剂量影响的生理和组织学变量无效。另一种NO供体硝普钠(2 μmol)在55分钟的观察期内产生的行为和细胞毒性作用较少,但引起更强烈且分布更广泛的代谢刺激,尤其是在连合和投射白质束中。这些结果为使用脑室内注射硝基化合物的清醒大鼠模型来研究脑中NO的生理、行为、代谢和细胞毒性特性奠定了基础。